Effect of short-term storage of blood samples on gene expression in lung cancer patients
Author:
Obermayr Eva1ORCID, Koppensteiner Nina1, Heinzl Nicole1, Schuster Eva1, Holzer Barbara1, Fabikan Hannah2, Weinlinger Christoph2, Illini Oliver23, Hochmair Maximilian J.23, Zeillinger Robert1
Affiliation:
1. Department of Obstetrics and Gynecology , Molecular Oncology Group, Comprehensive Cancer Center, Medical University of Vienna , Vienna , Austria 2. Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf , Vienna , Austria 3. Department of Respiratory and Critical Care Medicine , Klinik Floridsdorf, Vienna Healthcare Group , Vienna , Austria
Abstract
Abstract
Objectives
The stability of gene transcripts associated with the presence of circulating tumor cells (CTCs) has been predominantly studied in cultured cancer cell lines added to blood samples under artificial conditions. In the present study the effect of storage on CTC-related transcripts was assessed in blood samples taken from patients with non-small lung cancer (n=58).
Methods
The blood samples were split in two equal parts to compare the gene expression with and without storage for 24 h at ambient temperature without preservative added. After enrichment using the microfluidic Parsortix® technology, the expression levels of selected genes were assessed using quantitative PCR following a gene-specific pre-amplification. The prognostic relevance of each gene in fresh and stored blood samples was evaluated using the R-package Survminer.
Results
Some genes were either not affected (TWIST1, CDH5, CK19) or upregulated upon storage (NANOG, MET, UCHL1) but still associated with poor prognosis. In contrast, ERBB3, PTHLH, EpCAM, and TERT were no longer associated with the overall survival of the patients.
Conclusions
The study demonstrates the surprising stability of CTC-related transcripts, which makes overnight shipping of native blood samples possible. Careful verification is required when using model systems – such as normal blood spiked with tumor cells – or other CTC-related markers, as individual transcripts may respond differently to storage.
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Reference28 articles.
1. https://clinicaltrials.gov/ct2/results?term=circulating+tumor+cells&Search=Apply&recrs=a. 2. Zavridou, M, Mastoraki, S, Strati, A, Tzanikou, E, Chimonidou, M, Lianidou, E. Evaluation of preanalytical conditions and implementation of quality control steps for reliable gene expression and DNA methylation analyses in liquid biopsies. Clin Chem 2018;64:1522–33. https://doi.org/10.1373/clinchem.2018.292318. 3. Obermayr, E, Agreiter, C, Schuster, E, Fabikan, H, Weinlinger, C, Baluchova, K, et al.. Molecular characterization of circulating tumor cells enriched by A microfluidic platform in patients with small-cell lung cancer. Cells 2019;8. https://doi.org/10.3390/cells8080880. 4. Obermayr, E, Maritschnegg, E, Agreiter, C, Pecha, N, Speiser, P, Helmy-Bader, S, et al.. Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells. Oncotarget 2018;9:812–23. https://doi.org/10.18632/oncotarget.22549. 5. Stathopoulou, A, Ntoulia, M, Perraki, M, Apostolaki, S, Mavroudis, D, Malamos, N, et al.. A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer. Int J Cancer 2006;119:1654–9. https://doi.org/10.1002/ijc.22017.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|